Target Identification

The right move at the right time can be transformational. In life sciences, the best opportunities lie at the intersection of technology, market, team, and timing. DeciBio can filter the signal from the noise, and identify the best investment targets for your company or fund.

Our Experts

Stephane Budel

Miguel Edwards

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Internal Lab Buildout Strategy

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

Voice-of-Customer Research

Due Diligence

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Pharma & Biotech

Healthcare IT Solution Market Opportunity

A leading pharmaceutical & clinical diagnostics manufacturer wanted to understand the market opportunity for a novel multidisciplinary cancer conference IT support solution

Voice-of-Customer Research

Go-to-Market Strategy

Competitive Analysis

Pharma & Biotech

Cell Therapy Market Trends and Revenue Forecast

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

Revenue Projection

Clinical Diagnostics

Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing

A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution

Customer Segmentation

Voice-of-Customer Research

Market Landscaping and Sizing

Cell Line Market 5-Year Forecast

A large life science tools provider was interested in characterizing the genome engineering and engineered cell line market to identify potential opportunities to participate in the space

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help